Adenovirus IgM Plasma

Human-derived plasma for diagnostic assay development and research applications. Used in laboratory testing and therapeutic research protocols.

Recovered human plasma processed for in vitro diagnostic applications. This material is sourced from donor plasma and prepared to specifications for diagnostic reagent development.

Processed human plasma product for diagnostic and laboratory applications. Used in coagulation assays, immunoassays, and calibration of clinical laboratory instruments.

Human plasma or serum containing antibodies (IgM/IgG/IgA) against specific pathogens, suitable for manufacturing calibrators and positive controls in diagnostic assays.

Human serum and plasma samples from donors with specific disease states for diagnostic validation. Supports development and testing of disease-specific assays.

Processed human serum negative for anti-HAV IgM antibody. Manufactured in a cGMP, FDA-registered facility meeting ISO 13485:2016 standards. Plasma is collected from US FDA licensed facilities with complete donor traceability and negative pathogen testing.

Control materials for adenovirus diagnostic testing to validate the performance of adenovirus rapid diagnostic tests.

Purification reagent kit for adenovirus isolation and concentration from cell culture supernatants. Designed for gene therapy and vaccine development applications.

Single-use rapid test device for adenovirus detection. Provides quick identification of adenoviral infections.

Human serum with IgM antibodies depleted and lipids removed through delipidization. Designed for diagnostic assays where IgM interference must be minimized.

High-quality antibodies designed for in vitro diagnostic applications including immunoassays and serological testing. The antibodies are manufactured to pharmaceutical standards for diagnostic use.

Recombinant protein antigens for use in IVD test kit development and production. Provides standardized antigen material for immunoassay applications.